That is a clinically meaningful secondary benefit for patients with type 2 diabetes, but it is not the same as the weight loss observed in obesity-specific trials at higher doses
Rare neuro-ophthalmic events such as ophthalmic migraine warrant monitoring despite low incidence 64
This depends on your unique insurance plan, and coverage may vary for our membership plans, medication, and other services
In clinical practice, GLP-1 RAs are primarily employed to stabilize blood glucose levels in patients with diabetes, with established efficacy
Notably, persistent or new users of GLP-1 RAs exhibited better survival and kidney outcomes compared to ever users, with persistent users also showing superior MACEs and MAKEs outcomes
10.1210/en.2011-1795 26 DavidsonJ